Managed Account Advisors’s ResMed RMD Stock Holding History

Managed Account Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$372K	Sell	6,597 -108,667	-94%	-$6.86M	﹤0.01%	2362
2015 Q1	$8.27M	Buy	115,264 +6,072	+6%	+$394K	0.01%	1168
2014 Q4	$6.12M	Sell	109,192 -33,055	-23%	-$1.73M	0.01%	1296
2014 Q3	$7.01M	Sell	142,247 -4,891	-3%	-$249K	0.01%	1216
2014 Q2	$7.45M	Sell	147,138 -4,535	-3%	-$225K	0.01%	1157
2014 Q1	$6.78M	Buy	151,673 +2,555	+2%	+$115K	0.01%	1162
2013 Q4	$7.02M	Sell	149,118 -1,565	-1%	-$79.2K	0.01%	1142
2013 Q3	$7.96M	Buy	150,683 +138,575	+1,144%	+$6.72M	0.01%	1019
2013 Q2	$546K	Buy	+12,108	New	+$574K	﹤0.01%	1988

Other funds holding RMD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Managed Account Advisors's RMD Position: Q2 2015 in Review

Managed Account Advisors reduced its ResMed (RMD) stake by 94% in Q2 2015, selling an estimated $6.86M and leaving 6,597 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #2362.

Managed Account Advisors first reported a position in RMD in Q2 2013 and has held it in 9 quarters since. The position peaked at $8.27M in Q1 2015. 312 funds tracked by Wall St. Rank hold RMD as of Q2 2015.

Managed Account Advisors held 6,597 shares of ResMed worth $372K as of Q2 2015.
Managed Account Advisors sold 108,667 ResMed shares in Q2 2015, an estimated $6.86M.
ResMed made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2362 holding.
Managed Account Advisors first reported a position in ResMed in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's ResMed position peaked at $8.27M in Q1 2015.
312 funds tracked by Wall St. Rank held ResMed as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.